Sahlgrenska University Hospital
Gothenburg, VGR, 41345, Sweden
NCT Number: NCT01755338
The purpose of this study is to investigate if methylprednisolone is effective in reducing the cerebral inflammatory response after open heart surgery with cardiopulmonary bypass.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Gothenburg, VGR, 41345, Sweden
In a previous study we found that patients undergoing aortic valve surgery had elevated cerebrospinal inflammatory markers. In this study we aim to investigate if this inflammatory response can be reduced after treatment with steroids.
30 patients will be randomized to intraoperative treatment with either placebo or methylprednisolone 15mg/kg. CSF and blood will be collected the day before and the day after surgery, analyzed for markers of inflammation (IL-6, IL-8), neuronal damage (S-100) and blood brain barrier function (alb).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Methylprednisolone 15mg/kg
Other names: Solu-Medrol
Placebo
Other names: Sodium Chloride
Time frame: 24h after surgery
Time frame: 24h after surgery
Sahlgrenska University Hospital
Other
Effect of Steroids on Cerebrospinal Fluid Markers of Inflammation and Neuronal Damage After Surgical Aortic Valve Replacement
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06894550
Altitude, Altitude Sickness
Bern, Canton of Bern, Switzerland
View Trial DetailsNCT06211296
Aortic Stenosis, Aortic Valve Disease
Thousand Oaks, California, United States
View Trial DetailsNCT05035277
Aortic Stenosis, Aortic Valve Disease
Oslo, Norway
View Trial DetailsNCT06372301
Aortic Stenosis, Aortic Valve Disease
Aarhus, Denmark
View Trial Details